Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah H Fuller

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|April 1, 2024
Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centersKarsten Eichholz, Yoshinori Fukazawa, Christopher W Peterson, et al.
Nature|September 28, 2017
Massively parallel de novo protein design for targeted therapeuticsAaron Chevalier, Daniel-Adriano Silva, Gabriel J Rocklin, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animalsAlexander A Cohen, Jennifer R Keeffe, Ariën Schiepers, et al.
Cell|August 28, 2024
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animalsAlexander A Cohen, Jennifer R Keeffe, Ariën Schiepers, et al.
Cell Reports|August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceAlexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Plos Pathogens|March 13, 2020
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionGiacomo Gorini, Slim Fourati, Monica Vaccari, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Maternal Influenza A Virus Infection Induces Antiviral and Immune Dysregulation in the Placenta and Fetus Without Vertical TransmissionOrlando Cervantes, Sidney Sun, Hazel Huang, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|April 1, 2024
Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centersKarsten Eichholz, Yoshinori Fukazawa, Christopher W Peterson, et al.
Nature|September 28, 2017
Massively parallel de novo protein design for targeted therapeuticsAaron Chevalier, Daniel-Adriano Silva, Gabriel J Rocklin, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animalsAlexander A Cohen, Jennifer R Keeffe, Ariën Schiepers, et al.
Cell|August 28, 2024
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animalsAlexander A Cohen, Jennifer R Keeffe, Ariën Schiepers, et al.
Cell Reports|August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceAlexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Plos Pathogens|March 13, 2020
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionGiacomo Gorini, Slim Fourati, Monica Vaccari, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Maternal Influenza A Virus Infection Induces Antiviral and Immune Dysregulation in the Placenta and Fetus Without Vertical TransmissionOrlando Cervantes, Sidney Sun, Hazel Huang, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Pageof 7